id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-E-0221-0002,FDA,FDA-2003-E-0221,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-24T05:00:00Z,2003,11,,,2025-10-30T19:01:28Z,,0,0,090000648048cefa
FDA-2003-E-0221-0001,FDA,FDA-2003-E-0221,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2003-09-25T04:00:00Z,2003,9,,,2025-10-30T18:59:21Z,,0,0,090000648048ce94